Phase 2, open-label, multicenter study of the efficacy and safety of INCB054828 in patients (pts) with advanced, metastatic, or surgically unresectable cholangiocarcinoma (CCA) with inadequate response to prior therapy Meeting Abstract

  

Authors:	Borad, M. J.; Davis, S. L.; Lowery, M. A.; Lihou, C. F.; Abou-Alfa, G. K.
Abstract Title:	Phase 2, open-label, multicenter study of the efficacy and safety of INCB054828 in patients (pts) with advanced, metastatic, or surgically unresectable cholangiocarcinoma (CCA) with inadequate response to prior therapy
Meeting Title:	53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	35
Issue:	15 Suppl.
Meeting Dates:	2017 Jun 2-6
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2017-05-20
Start Page:	234s
Language:	English
ACCESSION:	WOS:000411931700007
DOI:	10.1200/JCO.2017.35.15_suppl.TPS4145
PROVIDER:	wos
Notes:	Meeting Abstract: TPS4145 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/147085